Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial
Nutrients · 2024
DOI: 10.3390/nu16111670 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Pariyarath Sangeetha Thondre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Brookes Centre for Nutrition and Health, Oxford OX3 0BP, UK. Hauptthemen laut MEDLINE: Cross-Over Studies, Plant Extracts, Morus, Blood Glucose. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Phynova Group Limited.
Abstract (Originalsprache)
Non-communicable diseases (NCDs) are becoming an increasingly important health concern due to a rapidly ageing global population. The fastest growing NCD, type 2 diabetes mellitus (T2DM), is responsible for over 2 million deaths annually. Lifestyle changes, including dietary changes to low glycemic response (GR) foods, have been shown to reduce the risk of developing T2DM. The aim of this study was to investigate whether three different doses of Reducose®, a mulberry leaf extract, could lower the GR and insulinemic responses (IR) to a full meal challenge in healthy individuals. A double-blind, randomised, placebo-controlled, repeat-measure, crossover design trial was conducted by the Oxford Brookes Centre for Nutrition and Health; 37 healthy individuals completed the study. Participants consumed capsules containing either 200 mg, 225 mg, 250 mg Reducose® or placebo before a test meal consisting of 150 g white bread and egg mayo filler. Capillary blood samples were collected at 15-min intervals in the first hour and at 30-min intervals over the second and third hours to determine glucose and plasma insulin levels. The consumption of all three doses of Reducose® resulted in significantly lower blood glucose and plasma insulin levels compared to placebo. All three doses of Reducose® (200 mg, 225 mg, 250 mg) significantly lowered glucose iAUC 120 by 30% (p = 0.003), 33% (p = 0.001) and 32% (p = 0.002), respectively, compared with placebo. All three doses of Reducose® (200 mg, 225 mg, 250 mg) significantly lowered the plasma insulin iAUC 120 by 31% (p = 0.024), 34% (p = 0.004) and 38% (p < 0.001), respectively. The study demonstrates that the recommended dose (250 mg) and two lower doses (200 mg, 225 mg) of Reducose® can be used to help lower the GR and IR of a full meal containing carbohydrates, fats and proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Brookes Centre for Nutrition and Health, Oxford OX3 0BP, UK.
- Department of Paediatrics, University of Oxford, Oxford OX3 9DU, UK.
- Phynova Group Limited, Banbury OX16 3ED, UK.
ORCID-Profile: Pariyarath Sangeetha Thondre, Isabel Butler, Jonathan Tammam, Andrew Gallagher
Förderung
- Phynova Group Limited
Zitieren
APA
Thondre, P. S., Butler, I., Tammam, J., Achebe, I., Young, E., Lane, M., & Gallagher, A. (2024). Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial. Nutrients. https://doi.org/10.3390/nu16111670
Vancouver
Thondre PS, Butler I, Tammam J, Achebe I, Young E, Lane M, et al. Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial. Nutrients. 2024. doi:10.3390/nu16111670
BibTeX
@article{Thondre2024,
author = {Thondre, Pariyarath Sangeetha and Butler, Isabel and Tammam, Jonathan and Achebe, Ifunanya and Young, Elysia and Lane, Michael and Gallagher, Andrew},
title = {Understanding the Impact of Different Doses of Reducose® Mulberry Leaf Extract on Blood Glucose and Insulin Responses after Eating a Complex Meal: Results from a Double-Blind, Randomised, Crossover Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16111670}
}
EUVIMED